Introduction {#s001}
============

O[besity is an]{.smallcaps} increasing health problem especially in the Western world. In Finland, as many as 35% of pregnant women are overweight,^[@B1]^ and the trend is worldwide.^[@B2],[@B3]^ Obesity predisposes mothers-to-be to various pregnancy complications, such as reduced insulin sensitivity, potentially followed by metabolic inflammation and gestational diabetes mellitus.^[@B4],[@B5]^ In addition, increased rates of pre-eclampsia, cesarean section, and preterm birth have been reported among obese women in comparison with their normal-weight counterparts,^[@B6]^

Furthermore, maternal obesity also affects infant outcomes, including congenital anomalies in the central nervous system and heart, as well as a higher fat percentage later in adolescence, and an increased risk for asthma and neuropsychiatric symptoms.^[@B6]^ In a similar manner, maternal gestational weight gain (GWG) above normal has been reported to serve as a potential risk factor for childhood obesity in the offspring.^[@B10]^

The human gastrointestinal tract is inhabited by a vast number of commensal microorganisms that are collectively referred to as gut microbiota (GM).^[@B11]^ This densely populated microbial ecosystem is a central component that affects host physiology and metabolism.^[@B11]^ GM contributes to the host\'s energy harvest from ingested nutrients by hydrolyzing and fermenting complex polysaccharides in the colon.^[@B11]^ The high diversity of these bacterial communities has been suggested to serve as a signature of a healthy gut ecosystem^[@B12]^ and on the other hand reduced bacterial diversity has been associated, for example, with obesity,^[@B13]^ inflammatory bowel disease (IBD)^[@B14]^ and a higher amount of chromogranin A, which is a marker of neuroendocrine activation.^[@B15]^ Thus, altered and somewhat distorted gut microbiota composition (GMC) may mediate the health implications of metabolic conditions such as obesity.^[@B16]^

Previously, certain shifts in GMC have been reported in obesity both in human and rodent studies.^[@B17]^ Fecal microbiota transplantation (FMT) studies conducted in germ-free mice have demonstrated that, despite a low-fat diet, transplantation from obese individuals causes greater fat accumulation in recipients compared with the mice receiving stools from lean phenotypes.^[@B21]^ In a human FMT study, improved insulin sensitivity, but no change in weight, was observed in obese patients with metabolic disturbances after stool transplantation from lean donors.^[@B22]^

Obese individuals seem to have a higher proportion of the Gram-positive *Firmicutes* phylum bacteria in their gut compared with their lean counterparts.^[@B18],[@B23]^ Additionally, several bacterial genera such as *Parabacteroides*, *Ruminococcus*, *Campylobacter*, *Dialister*, *Porphyromonas*, and *Staphylococcus* are associated with the obese phenotype.^[@B23]^ Maternal overweight has been previously linked, for example, to the GMC that contains higher abundance of bacterial species, such as *Staphylococcus aureus*, *Escherichia coli*, and other members of the family *Enterobacteriacaea*, and lower counts of species such as *Bifidobacterium longum* and *Bacteroides fragilis* compared with lean.^[@B24],[@B25]^

In addition, previous studies have reported complex results concerning the association between weight and proportion of the Gram-negative *B. fragilis* in expecting mothers. *B. fragilis* was reported to be more abundant in gestational week (gwk) 24 in lean mothers,^[@B24]^ but on the other hand, another study reported it to be more abundant in the first and third trimester in obese mothers compared with lean controls.^[@B25]^ However, in these studies, GM analyses were performed by fluorescent *in situ* hybridization coupled with flow cytometry (FCM-FISH) and quantitative real-time polymerase chain reaction (qPCR).

Normal GWG has been associated with greater abundance of *B. fragilis* in gwk 24,^[@B24]^ but excessive GWG has been associated with greater abundance of *Bacteroides/Prevotella* group.^[@B25]^ Moreover, excessive GWG has been associated with the higher fecal numbers of *E. coli* and prevalence of the members in the *Clostridium leptum* subgroup and *Staphylococcus.*^[@B24]^ Additionally, women with normal weight gain during pregnancy had increased numbers of *Bifidobacterium* and *Akkermansia muciniphila* in their gut in comparison with subjects with excessive weight gain.^[@B24]^ Furthermore, Koren et al. reported a reduced overall diversity of GM from the first to the third trimester and signs of increased insulin sensitivity and inflammation in pregnant women, which indicates shifts in GMC during pregnancy despite overweight.^[@B26]^

Obesity and mood disorders are highly likely to co-occur: obesity increases the risk of depression and vice versa.^[@B27]^ This comorbidity may be due to the high prevalence of both diseases,^[@B28],[@B29]^ drug therapy side effects,^[@B30]^ or shared inherited factors,^[@B31]^ however, the overlapping is still poorly understood. Additionally, altered GMC have been reported among patients with major depressive disorders.^[@B32]^ Due to co-occurrence, it is relevant to investigate these spectrums of symptoms together.

We used three approaches to investigate the connection of obesity, GWG, and GMC. First, the association between GMC and clinical markers was analyzed in the conventional way. Second, we used unsupervised data-driven statistical methods to cluster the population in two groups according to their GMC in genera level and analyzed the differences with clinical parameters. Third, we divided the study population into two groups dominated either by phylum *Bacteroidetes* or *Firmicutes* to compare the effects observed in unsupervised hierarchical clustering and further investigate the differences between the clinical parameters.

The aim of this study was to investigate the associations among the maternal body mass index (BMI), GWG, and GMC, and diversity in mid-pregnancy. We hypothesize that higher maternal BMI and elevated GWG are associated with distorted GMC and reduced diversity.

Materials and methods {#s002}
=====================

Subjects, weight measurements, questionnaire data {#s003}
-------------------------------------------------

Subjects were recruited from a larger study (FinnBrain Birth Cohort study; [www.finnbrain.fi](www.finnbrain.fi)) conducted in the southwest Finland. The study has been approved by the Joint Ethics Committee of the Hospital District of Southwest Finland and University of Turku. Subjects were contacted at gwk 22 by phone or e-mail. Fifty-two (65%) pregnant women agreed to participate, and 28 (35%) declined. The weight gain during pregnancy and self-reported prepregnancy weight were collected from the maternity welfare clinic documents. Subjects were weighed at least four times during the pregnancy and weight gain was classified based on the recommendations of the Institution of Medicine.^[@B3]^ The guideline value for the GWG of mothers with normal weight is 11.5--16 kg and of overweight or obese mothers 7.0--11.5 kg.^[@B33]^ Mothers were classified according to their prepregnancy BMI into three groups, obese ≥30.0 kg/m^2^, overweight 25.0--30.0 kg/m^2^, and normal weight \<25.0 kg/m^2^.

Information about maternal pre-eclampsia, pregnancy-induced hypertension, and gestational diabetes as well as neonatal measures and outcomes (mode of delivery, birth weight and height, gwks, and neonatal death) was collected from the National Birth Registry provided by the National Institute for Health and Welfare ([www.thl.fi](www.thl.fi)). Information about other medical conditions and medications was collected by means of self-reported questionnaires throughout the pregnancy.

All subjects (*n* = 52) were Caucasian females. None of the subjects reported inflammatory gastrointestinal disorders, such as IBD or type 1 or 2 diabetes. One subject, who had an early neonatal death and antimicrobial treatment, was excluded from the study and one sample was excluded due to low stool sample quality. Moreover, three subjects reported antibiotic treatment during the previous 2 months before the sample collection and they were excluded. One subject reported celiac disease and was excluded from the study due to recent knowledge that celiac disease has a major impact on GMC.^[@B34]^ Thus, altogether 46 subjects were included in the final analyses.

Prenatal maternal psychiatric symptoms were taken into account as a confounding variable in the statistical analyses. Symptoms were analyzed using self-reported questionnaires, including Pregnancy-Related Anxiety Questionnaire--Revised 2 (PRAQ-R2; total score 0--40),^[@B35]^ Edinburgh Postnatal Depression Scale (EPDS) (total score 0--30),^[@B36]^ and Symptom Checklist-90, anxiety subscale (SCL-90; total score 0--50)^[@B37]^ at gwk 24. Data on delivery, including mode of delivery, gestational age and weight, height, and sex of the newborn was obtained from the hospital records. Information on antibiotic treatments during the preceding 2 months, type 1 and 2 diabetes, celiac disease, and IBDs were self-reported. The season of when the sample collection took place was taken into account as a confounding variable, as seasonal variation in GMC has previously been reported at the population level.^[@B38]^ The seasons of the sampling time was divided into winter (December to February), spring (March to May), summer (June to August), and autumn (September to November).

Fecal sample collection and next-generation sequencing analysis of GMC {#s004}
----------------------------------------------------------------------

Subjects self-collected the stool samples at gwk 24 at their homes in sterile collection tubes according to the oral and written instructions. The samples were stored immediately at −20°C after the collection and brought to the laboratory on ice within 24 hours, after which the samples were stored at −75 °C for further analysis. Total DNA from the gently thawed fecal samples was extracted with GTX Stool Extraction Kit VER 2.0 and GenoXtract machine (Hain Lifescience, Nehren, Germany) as previously described.^[@B39]^ Before the extraction, the samples were mechanically homogenized with MO BIO PowerLyzer 24 Bench Top Bead-Based Homogenizer (MO BIO Laboratories) in 1.4 mm Ceramic Bead Tubes (MO BIO Laboratories), to enhance the cell lysis. The extractions were performed according to the manufacturer\'s instructions. The DNA concentrations were measured fluorometrically with the Qubit 2.0 dsDNA HS Assay Kit (Life Technologies), after which the DNAs were stored at −75°C.

The microbial profiles of the DNA extracts were analyzed with Illumina MiSeq 16S ribosomal RNA (rRNA) gene-sequencing protocol as previously described.^[@B39],[@B40]^ Briefly, an in-house protocol targeting the V4--V5 regions of the bacterial 16S rRNA gene was utilized in the analysis. The V4--V5 region was amplified using the HiFi PCR Kit (KAPA Biosystems, Wilmington, MA) with in-house-generated, indexed primers, modified from Kozich et al.^[@B41]^ The forward and reverse primer sequences for the V4--V5 rRNA gene library were: fwd 5′-AATGATACGGCGACCACCGAGATCTACAC-i5^[***a***]{.ul}^ TATGGTAATTGTGTGCCAGCMGCCGCGGTAA-3′ and rev 5′-CAAGCAGAAGACGGCATACGAGAT-i7^[***a***]{.ul}^-AGTCAGTCAGGCCCCGTCAATTCMTTTRAGT-3′, where i5 and i7 represent index sequences (eight nucleotides) enabling the identification of sequences originating from each prespecified DNA sample. The detailed information about the contents of the reactions and condition of the PCR have been described previously.^[@B40]^ The PCR products were purified with Agencourt AMPure XP magnetic beads (Beckman Coulter, Brea, CA) on the DynaMag-96 Side Magnet (Thermo Fisher Scientific), and their qualities were controlled by measurement with TapeStation (Agilent Technologies, Santa Clara, CA). Finally, the DNA concentrations of the purified products were measured with the Qubit 2.0 dsDNA HS Assay Kit (Life Technologies).

Raw reads across the 46 samples, sequenced with the Illumina MiSeq 300 bp paired-end sequencing, were used as an input for the data analysis that was performed as previously described.^[@B40]^ Reads were first quality filtered requiring at least a 20 Phred quality score, resulting in 51--428k reads per sample (mean: 103k, standard deviation: 52k). At the species level, 26% of the reads was identified as specific species, and at the genus level, 62% of reads was identified as specific genera. Due to the uncertainty of the species-level results, only genus and higher taxonomic levels were used for the analysis.

Statistical analyses {#s005}
--------------------

The statistical analyses were performed by using R 3.3.3.^[@B42]^ The subjects were divided into the two distinct subgroups based on the relative abundances of their bacterial genera. The grouping was performed using the unsupervised hierarchical complete-linkage clustering based on the Bray--Curtis dissimilarities. The identified clusters were characterized by notable tradeoff in the *Firmicutes* and *Bacteroidetes* dominance. The *Firmicutes--Bacteroidetes* ratio (the ratio between their relative abundance in each sample) was used to create groups dominated by *Bacteroidetes* (*Firmicutes/Bacteroidetes* ratio \<1) or *Firmicutes* (*Firmicutes/Bacteroidetes* ratio ≥1).

Alpha diversity indices (Shannon index, Chao1, and number of observed species) were calculated with the R vegan package.^[@B43]^ Beta diversity was calculated with unweighted and weighted UniFrac and the regression models were calculated with the adonis function from R vegan package as implemented in QIIME bioinformatics software.

Furthermore, the subject phenotypes were investigated based on the available clinical data (BMI, weight gain, questionnaire data) within the clusters. The statistical significance of the difference in distribution of categorical variables in the clusters was determined using Fisher\'s exact test as the number of subjects was modest. The difference in continuous variables was tested using the Wilcoxon\'s rank-sum test. The statistical relationships of two continuous variables, including Operational taxonomic unit (OTU) counts and relative proportions of bacteria, BMI and GWG, were investigated with Spearman\'s *rho*. *p*-Values were adjusted for multiple testing using Benjamini and Hochberg method.^[@B44]^

Results {#s006}
=======

Clinical characteristics of the study subjects {#s007}
----------------------------------------------

The characteristics of the study subjects (*n* = 46) regarding maternal BMI, GWG, season of sample taking, psychiatric symptoms, medical conditions, and neonatal measures and outcomes are described in [Table 1](#T1){ref-type="table"}. There was no correlation between prepregnancy BMI and GWG during pregnancy in the whole population (*r* = −0.190, *p* = 0.20). Weight gain during the pregnancy and weight gain until gwk 24 correlated positively (*r* = 0.412, *p* = 0.004). The symptom levels of depression and anxiety questionnaires varied from mild to moderate ([Table 1](#T1){ref-type="table"}). All the infants were born full term (gwks 37--42), except for one (gwk 36). No statistically significant correlations existed between the different bacterial taxa or Shannon index and depression or anxiety symptom scores.

###### 

[Clinical Characteristic of the Whole Population and Unsupervised Hierarchical and Firmicutes/Bacteroidetes Clustering]{.smallcaps}

  *Variable*                                                           *Total*   *%*    *Group 1*   *%*    *Group 2*   *%*    p       *Firmicutes group*   *%*    *Bacteroidetes Group*   *%*    p
  -------------------------------------------------------------------- --------- ------ ----------- ------ ----------- ------ ------- -------------------- ------ ----------------------- ------ --------
  *N*                                                                  46               12                 34                         28                          18                              
  Mother                                                                                                                                                                                         
   Age                                                                 36.1             30.9               32.5               0.26    31.8                        32.5                           0.62
   Weight                                                                                                                                                                                        
    BMI before pregnancy                                               24.6             24.1               24.8               0.61    23.3                        26.7                           0.13
    Weight before pregnancy                                            68.5             69.2               68.2               0.74    66.6                        71.5                           0.78
   Weight category                                                                                                                                                                               
    Normal weight                                                      35        76.1   9           75.0   26          76.5   0.3     24                   85.7   11                      61.1   0.028
    Overweight                                                         7         15.2   3           25.0   4           11.8           4                    14.3   3                       16.7    
    Obese                                                              4         8.7    0           0.0    4           11.8           0                    0.0    4                       22.2    
   Weight gain                                                                                                                                                                                   
    Weight gain during the pregnancy                                   13.25            10.9               14.1               0.025   12.1                        15                             0.023
    Weight change until gwk 24                                         6.4              5.8                6.6                0.46    5.8                         7.3                            0.067
   Weight gain category                                                                                                                                                                          
    Less than guidelines                                               13        28.3   5           41.7   8           23.5   0.18    11                   39.3   2                       11.1   0.054
    Within guidelines                                                  20        43.5   6           50.0   14          41.2           12                   42.9   8                       44.4    
    More than guidelines                                               13        28.3   1           8.3    12          35.3           5                    17.9   8                       44.4    
   Weight gain during pregnancy according to the prepregnancy weight                                                                                                                             
    Normal weight                                                      13.8             11.4               14.7               0.043   12.5                        16.7                           0.0077
    Overweight                                                         12.5             9.5                14.8               0.37    10                          15.8                           0.59
    Obese                                                              9.7                                 9.7                                                    9.7                             
   Season                                                                                                                                                                                        
    Fall                                                               3         6.5    8           66.7   12          35.3   0.24    3                    10.7   0                       0.0    0.62
    Spring                                                             10        21.7   1           8.3    9           26.5           8                    28.6   2                       11.1    
    Summer                                                             13        28.3   2           16.7   11          32.4           10                   35.7   3                       16.7    
    Winter                                                             20        43.5   8           66.7   12          35.3           18                   64.3   2.0                     11.1    
   Stress                                                                                                                                                                                        
    PRAQ, sum                                                          22.7             23.0               22.5               0.9     22.6                        22.8                           1
    PRAQ, factor 1                                                     6.3              6.6                6.3                0.9     6.3                         6.5                            0.62
    PRAQ, factor 2                                                     8.9              8.5                9.0                0.8     9.0                         8.7                            0.55
    PRAQ, factor 3                                                     7.4              7.9                7.2                0.4     7.3                         7.6                            0.71
    SCL, sum                                                           2.8              3.1                2.7                0.6     2.7                         2.9                            0.47
    EPDS, sum                                                          4.0              4.5                3.8                0.5     3.7                         4.5                            0.70
  Infant                                                                                                                                                                                         
   Gender                                                                                                                                                                                        
    Boy                                                                18        39.1   5           41.7   13          38.2   1.00    10                   35.7   8                       44.4   0.77
    Girl                                                               28        60.9   7           58.3   21          61.8           18                   64.3   10                      55.6    
    Duration of the gestation                                          40               40                 40                 0.42    40                          39                             0.025
    Birth weight                                                       3540             3525               3545               0.8     3566                        3397                           0.42
    Birth height                                                       50.6             50.9               50.4               0.75    50.8                        49.4                           0.17
   Mode of delivery                                                                                                                                                                              
    Vaginal                                                            37        80.4   11          91.7   26          76.5   1       23                   82.1   14                      77.8   0.81
    C-section                                                          8         17.4   1           8.3    7           20.6           4                    14.3   4                       22.2    
  Maternal diseases                                                                                                                                                                              
   Pre-eclampsia                                                       1         2.2    0           0.0    1           2.9    1       0                    0.0    1                       5.6    1
   Gestational diabetes                                                4         8.7    1           8.3    3           8.8    1       2                    7.1    2                       11.1   0.34
   Gestational hypertension                                            3         6.5    1           8.3    2           5.9    1       2                    7.1    1                       5.6    1

Group 1 and 2 formed by hierarchical clustering.

BMI, body mass index; EPDS, Edinburgh Postnatal Depression Scale; gwk, gestational week; PRAQ, Pregnancy-Related Anxiety Questionnaire; SCL, Symptom Checklist, anxiety subscale.

Bacterial characteristics {#s008}
-------------------------

Fecal microbiota of the subjects was dominated by *Firmicutes* (average over complete study population 53.3%) and *Bacteroidetes* (45.9%). Other phylum such as *Proteobacteria*, *Tenericutes*, *Cyanobacteria*, *Actinobacteria*, *Lentisphaerae*, *Fusobacteria*, and *Verrucomicrobia* were detected from the samples with proportions \<0.5% on average ([Table 2](#T2){ref-type="table"}). More detailed bacterial abundance data are attached in the [Supplementary Table S1](#SD1){ref-type="supplementary-material"} (Supplementary Data are available online at [www.liebertpub.com/jwh](www.liebertpub.com/jwh)). The abundances of bacterial genera or phyla did not significantly correlate with either prepregnancy BMI or GWG. Furthermore, alpha and beta diversity were not related to the prepregnancy BMI or GWG.

###### 

[Alpha Diversity Indices According Groups]{.smallcaps}

  *Diversity*               *Mean*   *Group 1*   *Group 2*   p       *Firmicutes group*   *Bacteroidetes group*   p
  ------------------------- -------- ----------- ----------- ------- -------------------- ----------------------- --------
  Shannon index             2.11     2.27        2.05        0.058   2.24                 1.92                    0.0072
  Chao1                     49.72    50.51       49.44       0.64    50.84                47.98                   0.068
  No. of observed species   48.5     49.42       48.18       0.48    50.32                45.67                   0.0047

Group 1 and 2 formed by hierarchical clustering.

Hierarchical clustering {#s009}
-----------------------

Hierarchical clustering of the GM data by the relative abundancies of OTUs at the genus level was performed to elucidate the different subgroups in the population. Subjects were divided into two groups (group 1, *n* = 12; group 2, *n* = 34) based on the unsupervised hierarchical clustering. Group 1 was dominated by Gram-positive *Firmicutes* and group 2 by Gram-negative *Bacteroidetes* phylum (*p* \< 0.005 for both, [Table 2](#T2){ref-type="table"}). There were no significant differences in the alpha diversity indices between the two groups (*p* \> 0.05, [Table 3](#T3){ref-type="table"}). The Adonis statistics showed that groups were associated with unique GMC using weighted UniFrac analysis (*R*^[@B2]^ = 0.25, *p* = 0.001, [Fig. 1A](#f1){ref-type="fig"}), but not unweighted UniFrac analysis (*R*^[@B2]^ = 0.021, *p* = 0.44).

![Weighted UniFrac analyses according to **(A)** unsupervised hierarchical clustering (*R*^[@B2]^ = 0.25, *p* = 0.001) and **(B)** *Firmicutes*/*Bacteroidetes*-dominated groups (*R*^[@B2]^ = 0.41, *p* = 0.001).](fig-1){#f1}

###### 

[Mean Relative Abundances of Phyla According Groups]{.smallcaps}

  *Phylum*            *Mean relative abundance*   *Group 1*   *Group 2*   p         *Firmicutes group*   *Bacteroidetes group*   p
  ------------------- --------------------------- ----------- ----------- --------- -------------------- ----------------------- ---------
  *Actinobacteria*    0.11                        0.14        0.10        0.8193    0.14                 0.08                    1.0000
  *Bacteroidetes*     45.90                       28.72       51.96       \>0.005   34.91                63.00                   \>0.005
  *Cyanobacteria*     0.02                        0.01        0.02        0.7241    0.03                 0.00                    0.0499
  *Firmicutes*        53.32                       70.20       47.36       \>0.005   64.08                36.57                   \>0.005
  *Fusobacteria*      0.01                        0.00        0.01        0.7241    0.01                 0.01                    0.7257
  *Lentisphaerae*     0.01                        0.01        0.01        1.0000    0.01                 0.00                    0.2042
  *Proteobacteria*    0.31                        0.28        0.32        0.9912    0.35                 0.24                    0.8865
  *Tenericutes*       0.27                        0.54        0.18        0.7241    0.40                 0.08                    0.0366
  *Verrucomicrobia*   0.01                        0.01        0.01        0.9461    0.01                 0.00                    0.4081
  *Other*             0.06                        0.10        0.04        0.7241    0.08                 0.02                    0.4061

Group 1 and 2 formed by hierarchical clustering.

The clinical characteristics of both the groups are presented in [Table 1](#T1){ref-type="table"}. Group 2 had a higher GWG (*p* = 0.025), but no other differences (maternal prepregnancy BMI or weight, the weight gain category, maternal age, seasonal division, or depression or anxiety symptoms) between the groups existed (*p* \> 0.05 for all). There were no differences in the neonatal measures and outcomes between the groups (*p* \> 0.05 for all). Maternal medical conditions were evenly distributed between the two groups.

*Firmicutes* and *Bacteroidetes*-dominated groups {#s010}
-------------------------------------------------

Clustering by *Firmicutes/Bacteroidetes* ratio was performed to compare unsupervised hierarchical clustering groups and observed clinical differences. The *Firmicutes*-dominated group (*n* = 28) had lower GWG than *Bacteroidetes*-dominated group (*n* = 18), the *Bacteroidetes* group having a higher mean GWG than the *Firmicutes* group (15.0 vs. 12.1 kg, respectively, *p* = 0.023); the effect was more prominent among normal-weight mothers (16.7 vs. 12.5 kg, respectively, *p* = 0.0077) ([Table 1](#T1){ref-type="table"}). The distribution of weight categories (normal, overweight, obese) was different between the groups (*p* = 0.028), the *Firmicutes* group having higher proportion of normal-weight mothers (85.7% vs. 61.1% in Bacteroidetes group). The duration of gestation was longer in the *Firmicutes* group (*p* = 0.025), whereas other selected neonatal measures and outcomes or maternal characteristics were similarly distributed between the groups. Maternal medical conditions were evenly distributed among the groups ([Table 1](#T1){ref-type="table"}). The Shannon index (*p* = 0.0072) and the number of observed species (*p* = 0.0047) were higher in the *Firmicutes* group, whereas Chao1 did not differ between the groups ([Table 2](#T2){ref-type="table"}). The Adonis statistics showed that the groups were associated with unique GMC using unweighted (*R*^[@B2]^ = 0.066, *p* = 0.002) and weighted UniFrac analysis (*R*^[@B2]^ = 0.41, *p* = 0.001, [Fig. 1B](#f1){ref-type="fig"}).

Discussion {#s011}
==========

The earlier findings concerning GMC in general populations cannot be directly applied to pregnant women as the physiology of various organ systems, including the gastrointestinal tract is different during pregnancy.^[@B45]^ Pregnancy is a turbulent physiological state with altered energy metabolism and GMC and diversity.^[@B26]^ To date, there are only a limited number of studies that have concentrated on GMC during pregnancy, and, in addition, how it is associated with GWG and maternal BMI. Furthermore, these studies have reported varying results, especially regarding the role of *B. fragilis* within the *Bacteroidetes* phylum on prepregnancy weight and GWG.^[@B24],[@B25]^ The current study offers new insight into this debatable topic.

In line with the earlier studies, the tradeoff between the *Firmicutes* and *Bacteroidetes* phyla was a main driving factor for the population variation in microbiota composition, as the individuals could be clustered into two distinct groups dominated either by *Firmicutes* or *Bacteroidetes*. The dominance of *Bacteroidetes* was associated with the elevated GWG, especially among mothers with normal weight before pregnancy.

Previously, the phylum *Bacteroidetes* has been considered as a microbiological trait that associates to the lean phenotype and weight loss.^[@B16],[@B18]^ However, contradictory results have been reported^[@B46]^ and our study does not show associations between BMI and *Bacteroidetes* phylum. A study by Collado et al. reported that *B. fragilis*, within the *Bacteroidetes* phylum, was more abundant in overweight mothers-to-be in the first and third trimesters and further correlated with the GWG in the third trimester.^[@B25]^ However, in a study conducted by Santacruz et al., the proportion of *B. fragilis* in gwk 24 correlated with normal weight and normal GWG.^[@B24]^ Some of the discrepancies between the studies can be explained by the different sampling season and the characteristics of the participant population, such as variance in weight and geographical distribution. Furthermore, the results presented by the previous literature were conducted by either FCM-FISH or qPCR-based methods and thus describe species-level results. On the other hand, the current article describes the higher taxonomic levels.

Notably, the groups formed by the *Firmicutes/Bacteroidetes* ratio served a more straightforward clinical interpretation in terms of the maternal weight and GWG than the unsupervised grouping based on the overall genus-level composition. Additionally, the duration of gestation was lower in the *Bacteroidetes*-enriched group, whereas the clinical implication is more debatable as other neonatal measures and outcomes did not differ among the groups. Moreover, the *Bacteroidetes*-enriched group had a lower alpha diversity, which previously has been associated with overweight/obese phenotype and higher weight gain in the nonpregnant population.^[@B47]^ Additionally, Koren et al. reported a decrease in alpha diversity from first to third trimester,^[@B26]^ but this has not been replicated.^[@B48]^ Stanislawski et al. showed that postpartum alpha diversity was lower in obese/overweight mothers, but no association between GWG and alpha diversity was observed.^[@B49]^

In our study, the Illumina MiSeq sequencing approach was used to analyze the GMC. This offers a more holistic view of the microbial communities within the gut than the targeted approaches used in the previously mentioned studies conducted with pregnant women.^[@B24],[@B25]^ Conclusively, more studies are needed to evaluate the role of GMC and especially members of the phylum *Bacteroidetes* on gestational health.

The seasons of the sampling and psychiatric symptoms were taken into account in statistical analyses as confounding factors. Seasonal variation might affect the GMC at least at the population level,^[@B38]^ and there is great co-occurrence of obesity and depressive symptoms.^[@B27]^ However, neither season nor psychiatric symptoms seemed to influence the GMC or clustering analyses, indicating that the season of sampling time or psychiatric symptoms do not affect the connection between GWG and GMC. Additionally, pregnancy-related conditions (pre-eclampsia, gestational diabetes, and gestational hypertension) were taken into account, as the microbiome of various sites, mainly vaginal microbiome, can affect major obstetric conditions.^[@B50]^ In the current study, however, the subjects with obstetric conditions did not seem to affect the clustering, and thus were included in the study. In addition, the prepregnancy state of GMC, which forms the baseline for our analysis, is unknown. Hence, this study is associative rather than causative. Longitudinal studies with larger study populations would be essential to reveal the relationship between GWG and GMC in pregnant populations. Additionally, the recording of the dietary intake was not possible to include in this study, which is a limitation. Despite these limitations, our study provides support for the hypothesis of a connection between GMC and weight gain in pregnant populations.

Conclusion {#s012}
==========

Excessive GWG was associated with distinct GMC in mid-pregnancy, with *Bacteroidetes* being prominent and *Firmicutes* being less prominent in the GMC among those with increased GWG. Moreover, reduced alpha diversity was observed among the *Bacteroidetes*-dominated subjects. Longitudinal research is needed to further illustrate the relationship between *Bacteroidetes* and weight and GWG in pregnant populations and to show how this affects infant health.
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